Syncope, a transient loss of consciousness (TLOC) due to global cerebral hypoperfusion, is a common clinical presentation with a broad differential diagnosis. It accounts for approximately 1-3% of Emergency Department visits and up to 6% of hospital admissions. This article aims to provide a comprehensive approach to diagnosing syncope, to help healthcare professionals distinguish between benign and potentially life-threatening causes.
Syncope can be broadly divided into three categories: reflex (neurally mediated), cardiac, and orthostatic hypotension. Reflex syncope, the most common type, includes vasovagal syncope, situational syncope, and carotid sinus syndrome. Cardiac syncope can be due to arrhythmias or structural heart disease, while orthostatic hypotension is often related to medications or volume depletion.
A thorough history and physical examination are the cornerstones of the evaluation. Important elements include the description of the event, associated symptoms, triggers, and family history. The physical examination should focus on blood pressure measurements in different positions, cardiac examination, and neurological evaluation.
The initial diagnostic work-up includes an electrocardiogram (ECG), basic metabolic panel, complete blood count, and orthostatic vital signs. Further testing, such as echocardiography, tilt-table testing, or event monitoring, may be indicated based on the initial findings and clinical suspicion.
Management of syncope is tailored to the underlying cause. It may include lifestyle modifications, discontinuation or adjustment of medications, cardiac pacing, or treatment of underlying cardiac or neurological conditions.
Decoding syncope requires a systematic approach, from understanding the underlying mechanisms to performing a thorough clinical evaluation and appropriate diagnostic testing. By adopting this comprehensive approach, healthcare professionals can accurately diagnose and manage this common but often puzzling condition.
1.
New guidelines for radiation therapy for HPV-associated head and neck cancer
2.
Cancer mortality continuing to decline, says report
3.
Getting Lung Cancer Screening Staff Involved Improved Tobacco Cessation
4.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
5.
Adding Targeted Agent to Perioperative Therapy for RCC May Improve Disease Control
1.
Different Types of Blood Dyscrasias
2.
Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study
3.
Lymphomatoid Papulosis: What You Need to Know
4.
MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed
5.
Rare Malignant Ovarian Tumors: A Comprehensive Review for Clinicians
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Clinical Insights in Oncology
2.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
3.
Exploring Best Possible Treatment Strategies in Advanced Urothelial Carcinoma- A Panel Discussion
4.
Navigating the Complexities of Ph Negative ALL - Part XI
5.
Benefits of Treatment with CDK4/6 Inhibitors in HR+/HER2- aBC in Clinical Trials and the Real World
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation